Gregory Grunberg

Gregory Grunberg has made 56 investments in companies such as: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics, Esperion Therapeutics, Aptus Endosystems, Cydan, Jazz Pharmaceuticals, Eargo, Orbus Therapeutics, LEXEO Therapeutics, RxSight, InfaCare Pharmaceutical, Aptinyx, Somatus, Talaris Therapeutics, KaNDy Therapeutics, Dascena, Venus Concept, Epirium Bio, Axonics Modulation Technologies, Tricida, Practice Fusion, Amphora Medical, Neurana Pharmaceuticals, Collegium Pharmaceutical, Sublimity Therapeutics, Rapid Micro Biosystems, Velomedix, Polares Medical, PixelOptics, Vera Therapeutics, Checkmate Pharmaceuticals, Vaxcyte, CuraSen Therapeutics, Civitas Therapeutics, Solta Medical, Alphaeon, Amunix, BAROnova, Poseida Therapeutics, Molecular Templates, Helomics, Sympara Medical, PreCision Dermatology, Tiburio Therapeutics, Corcept Therapeutics, Aimmune Therapeutics, MURJ, 89bio, Inozyme, AqueSys, Kala Pharmaceuticals, Encore Dermatology, Whitehill Technologies, Endeavor BioMedicines.

Location of Gregory Grunberg is Menlo Park, United States.

The free version of Angel Match provides limited data for Gregory Grunberg. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.

Gregory Grunberg is a Managing Director and he his investment types are: Venture Capital.
Gregory Grunberg focuses investing in industries such as: Biotechnology, Health Care, Health Diagnostics, Medical Device, Women Founded, Women Led, Medical, Product Research, Information Technology, Pharmaceutical, Travel, Consumer Software, Software, Developer Platform, Therapeutics, Life Science, Audio, Wearables.

A short brief about investor:


Past investments

Social media:

Available after registration.